Janine Thomas
Investor Relations
Replay available
Outlook Therapeutics, Inc. (OTLK) Q3 2024 Earnings Call
Outlook Therapeutics, Inc. (NASDAQ: OTLK) Q3 2024 earnings conference call, held 2024-08-14. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Russell Trenary
President and Chief Executive Officer
Lawrence Kenyon
Chief Financial Officer
Julian Harrison
Analyst, BTIG
Will Hiddell
Analyst, Brookline Capital Markets
Tim Chang
Analyst, Capital One
Douglas Sao
Analyst, HC Wainwright
Daniel Godolin
Analyst, Chardan
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Outlook Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.029 -- 00:00:03.941 Greetings and welcome to the Outlook Therapeutics Corporate Third Quarter Fiscal Year 00:00:03.941 -- 00:00:05.372 2024 00:00:05.372 -- 00:00:10.374 Update Conference Call and Webcast. At this time, all participants are on a listen-only 00:00:10.374 -- 00:00:14.757 mode. A question and answer session will follow the formal presentation. 00:00:14.757 -- 00:00:18.639 If anyone should require operator assistance during the conference, please press star 00:00:18.639 -- 00:00:23.701 zero on your telephone keypad. As a reminder, this conference is being recorded. 00:00:23.701 -- 00:00:27.923 It is now my pleasure to introduce your host, Janine Thomas, Investor Relations. 00:00:27.923 -- 00:00:30.938 Thank you. Please go ahead. Thank you, Donna. 00:00:30.938 -- 00:00:34.740 At this time, I'd like to remind our listeners that remarks made during this webcast 00:00:34.740 -- 00:00:39.943 may state management's intentions be least expectations for future projections, including 00:00:39.943 -- 00:00:45.006 but not limited to our expectations about the timing of clinical trials 00:00:45.006 -- 00:00:49.088 and commercial launch and the sufficiency of our cash resources. 00:00:49.088 -- 00:00:52.250 These are forward-looking statements and involve risks and uncertainties. 00:00:52.250 -- 00:00:55.732 Forward-looking statements on this call are made pursuant to the safe harbor provisions 00:00:55.732 -- 00:01:00.849 of the Federal Security Laws and are based on Outlook Therapeutics' current expectations, 00:01:00.849 -- 00:01:03.350 and actual results could differ materially. 00:01:03.350 -- 00:01:07.233 As a result, you should not place undue reliance on any forward-looking statements. 00:01:07.233 -- 00:01:11.997 Some of the factors that could...